Cancer Treatment and Research Communications Volume 34 to 36

Journal Announcement: Cancer Treatment and Research Communications

Cancer Treatment and Research Communications is an esteemed international peer-reviewed journal committed to advancing the field of oncology through comprehensive basic, translational, and clinical research. In a significant development, starting from January 2020, Cancer Treatment and Research Communications has transitioned to an open-access model. This change ensures that authors who publish in the journal can make their work immediately, permanently, and freely accessible to the global scientific community.

Key Areas of Focus in Cancer Treatment and Research Communications Include:

1. Detection, Diagnosis, Prevention, and Treatment of Cancer: The journal welcomes research articles covering all aspects of cancer detection, diagnosis, prevention, and innovative treatment strategies.
2. Comprehensive Oncology Research: Cancer Treatment and Research Communications is dedicated to fostering research in diverse areas, including basic, translational, and clinical oncology.
3. Mechanistic Approaches in Tumor Types: The journal encourages investigations into the mechanistic underpinnings of cancer development and progression across different tumor types.
4. Cancer Biology: Articles exploring the intricate biology of cancer, including molecular carcinogenesis, cancer genetics, genomics, and cancer stem cells, are welcomed.
5. Molecular and Cellular Oncology: Research delving into molecular and cellular aspects of oncology, as well as systems biology and immuno-oncology, is a focal point.
6. Chemoprevention Strategies: The journal promotes studies on strategies for preventing cancer through interventions such as chemoprevention.
7. Advanced Therapeutic Approaches: Cancer Treatment and Research Communications encourages the exploration of gene therapy, antisense therapy, novel treatment strategies, and drug sensitivity and resistance.
8. Pathology of Cancer: Articles addressing the pathology of cancer, prognostic and predictive markers, and the development of innovative treatment approaches are sought.
9. Clinical Studies in Oncology: The journal places emphasis on prospective early-phase clinical trials in oncology, contributing to the advancement of patient care.

Mission of Cancer Treatment and Research Communications:

The mission of Cancer Treatment and Research Communications is to serve as a premier source of pertinent information in the field of oncology. The journal accomplishes this mission by promoting excellence in research and facilitating the timely translation of scientific discoveries into healthcare and clinical practice.

Peer-Reviewed Article Types:

The journal publishes various types of peer-reviewed articles, including:

• Original Reports: Research articles presenting original findings in oncology.
• Reviews: Comprehensive reviews of specific topics or recent advancements in cancer research and treatment.
• Editorials: Expert commentary and insights on key issues in oncology.

Cancer Treatment and Research Communications does not consider case reports or articles related to cancer policy.

Open Access and Copyright:

As an open-access journal, Cancer Treatment and Research Communications provides authors with the opportunity to publish their work openly, with articles freely accessible to the global research community. Authors will be responsible for an article publishing charge (APC) and have the flexibility to choose from various licensing options while retaining copyright to their published work.

The journal welcomes contributions from researchers, clinicians, and experts across the spectrum of oncology. All content is published in the English language, facilitating international accessibility and collaboration.

Volume 34: 2023

Volume 35: 2023

Volume 36: 2023